Outcomes of Pasi and Pasi Components in Two Phase 3 Trials of Deucravacitinib in Patients with Moderate to Severe Plaque Psoriasis

AuthID
P-019-040
12
Author(s)
Lebwohl, M
·
Gooderham, M
·
Warren, RB
·
Thaçi, D
·
Foley, P
·
Gottlieb, AB
·
Popmihajlov, Z
·
Jou, Y
·
Linaberry, M
·
Daamen, C
·
Griffiths, CEM
Document Type
Article
Year published
2025
Published
in Clinical and Experimental Dermatology, ISSN: 0307-6938
Indexing
Publication Identifiers
Source Identifiers
ISSN: 0307-6938
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.